Taiwan
Formosa Pharmaceuticals and AimMax Therapeutics Submit NDA to US FDA for APP13007 for Post-Operative Pain and Inflammation after Ocular Surgery.
This proprietary homogeneous nanosuspension has a solution-like appearance which offers great comfort to the eyes and enhanced drug penetration into ocular...
May 05, 2023 | News
Why Pharma and Medtech manufacturers are striving for digital maturity
Why pharma and medtech manufacturers are striving for...
April 25, 2023 | News
BIO Asia-Taiwan 2023: Asia's Largest Biotech Gathering
BIO Asia–Taiwan 2023 - Register Now Asia’s largest bioindustry-focused gathering, BIO Asia–Taiwan 2023, will be held July 26th t...
April 18, 2023 | News
Bora Pharmaceuticals and Celltrion Partners to Expand OSD capabilities in APAC market
The range of oral dosage form products will be manufactured at Bora’s Zhunan Site, which is one of the largest US FDA and MHRA-approved pharmaceutica...
April 10, 2023 | News
Taiwan's Compal Electronics Launches "AblatePal" RF Ablation System and "BreathePal" Bilevel Ventilator in Medical Device Market
The "AblatePal" RF ablation system uses the heat energy generated by electrical resistance when the current passes through the tissue to cauterize the tumo...
April 07, 2023 | News
AnnJi Pharma and Avenue Therapeutics Enter Licensing Agreement for Clinical Asset AJ201 to Treat Kennedy's Disease.
Under the terms of the license agreement, AnnJi will receive upfront payments of $3 million and is entitled to receive future development, regula...
March 13, 2023 | News
BRIM appoints Andrew Lin as Chairman and Dr. Wen Chyi Shyu as CEO, secures $18M in Series E funding, and advances clinical trials for Dry Eye Disease and Neurotrophic Keratitis treatments
What led to the decision to elect Andrew Lin as the new Chairman of the Board, and how do you believe he will contribute to BRIM's continued succ...
March 01, 2023 | Opinion
BRIM Biotechnology announces new leadership team
BRIM Biotechnology, Inc. (BRIM, TPEx 6885), a clinical-stage company developing novel regenerative therapies to help combat and cure ophthalmology and...
February 21, 2023 | News
Gilead to present data at APASL 2023 on effective models for monitoring and treating hepatitis C and efficacy of antiviral treatments for HIV-1 and HBV-coinfected adults
-- Study recommends a simplified strategy for baseline testing and minimal monitoring for treatment of hepatitis C virus (HCV) infection with ...
February 15, 2023 | News
Ubitus and Smart Surgery enable doctors to practice robotic surgery with VR streaming
Immersive simulation surgery practice with VR gears Ample practices are required for a medical student or even a doctor to become a skillful surgeon opera...
December 23, 2022 | News
BRIM Biotechnology, Inc. raises $20 million in Series E funding round
Since the company’s inception in 2013, BRIM has successfully developed several platform technologies, including the regenerative peptide technology (...
December 05, 2022 | News
Medeologix Acquires Three Silicon Valley Medical Device CDMO Companies
Medeologix, a Taiwan MedTech CDMO company announces its successful acquisition of three premier medical device manufacturing companies to form an integrate...
November 29, 2022 | News
Everest Medicines Announces Major Regulatory Updates in Taiwan and South Korea
-- Taiwan Food and Drug Administration grants Accelerated Approval Designation (AAD) to Nefecon -- -- Ministry of Food and Drug Safety in S...
November 28, 2022 | News
Qmed Asia Eyes APAC Expansion with Digital Health Solutions
Qmed Asia’s whirlwind MOU signings with MeetDoctor in Cambodia and Eucare Co. Ltd. from Taiwan to enable access to reliable and affordable digital ...
November 18, 2022 | News
Most Read
- Lack of Regular Screening Fuels Rise in Late-Stage Breast Cancer in Hong Kong, New Report Reveals
- BIOCHINA 2025: Connecting Global Innovators with China's Leading Biotech Firms
- Leon Wyszkowski, President of Analytical Services, Discusses Thermo Fisher's Strategic Move: Expanding Bioanalytical Capabilities in Europe with New Sweden Lab
- The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia
- Redefining Patient Safety in the Age of Healthtech
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
